Increased Levels of sENG and sVCAM-1 and Decreased Levels of VEGF in Severe Preeclampsia

American Journal of Hypertension

Volumn 29, Issue 11, 2016, Pages 1307-1310

  Rios, Danyelle Romana Alves ^a   Alpoim, Patricia Nessrala ^b   Godoi, Lara Carvalho ^b   Perucci, Luiza Oliveira ^b   De Sousa, Lirlândia Pires ^b   Gomes, Karina Braga ^b   Dusse, Luci Maria Santana ^b  

^a FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

adhesion molecule; angiogenesis; early and late preeclampsia; endothelial dysfunction; hypertension

Indexed keywords

ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; ENG PROTEIN, HUMAN; VASCULOTROPIN A;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; CASE CONTROL STUDY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PREGNANCY; PROSPECTIVE STUDY;

CASE-CONTROL STUDIES; ENDOGLIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NEOVASCULARIZATION, PATHOLOGIC; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84995394491     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpv170     Document Type: Article

References (28)

1. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
2. American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Gynecologists ACoOa, pregnancy TFoHi. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122:1122-1131.
3. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003; 22:143-148.
4. Cockell AP, Learmont JG, Smarason AK, Redman CW, Sargent IL, Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 1997; 104:235-240.
5. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16:5-15.
6. Dusse LM, Rios DRA, Pinheiro MB, Cooper AJ, Lwaleed BA. Preeclampsia: relationship between coagulation, fibrinolysis and inflammation. Clinica Chimica Acta 2011; 412:17-21.
7. Molvarec A, Szarka A, Walentin S, Beko G, Karadi I, Prohaszka Z, Rigo J Jr. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol 2011; 9:124.
8. Conti E, Zezza L, Ralli E, Caserta D, Musumeci MB, Moscarini M, Autore C, Volpe M. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? Cytokine Growth Factor Rev 2013; 24:411-425.
9. Bhavina K, Radhika J, Pandian SS. VEGF and eNOS expression in umbilical cord from pregnancy complicated by hypertensive disorder with different severity. Biomed Res Int 2014; 2014:982159.
10. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649.
11. Farzadnia M, Ayatollahi H, Hasan-Zade M, Rahimi HR. A comparative study of serum level of vascular cell adhesion molecule-1 (sVCAM- 1), intercellular adhesion molecule-1 (ICAM-1) and high sensitive C-reactive protein (hs-CRP) in normal and pre-eclamptic pregnancies. Iran J Basic Med Sci 2013; 16:689-693.
12. Higgins JR, Papayianni A, Brady HR, Darling MR, Walshe JJ. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol 1998; 179:464-469.
13. Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda) 2009; 24:58-71.
14. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. Am J Obstet Gynecol 2001; 184:998-1003.
15. Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 2010; 37:239-253.
16. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683.
17. Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers 2006; 10:515-527.
18. Cerdeira AS, Karumanchi SA. Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia. Scand J Clin Lab Invest Suppl 2010; 242:73-78.
19. Agarwal I, Karumanchi SA. Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens 2011; 1:17-21.
20. Hertig A, Liere P. New markers in preeclampsia. Clin Chim Acta 2010; 411:1591-1595.
21. Tache V, LaCoursiere DY, Saleemuddin A, Parast MM. Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity. Hum Pathol 2011; 42:1283-1288.
22. Vaisbuch E, Whitty JE, HassFan SS, Romero R, Kusanovic JP, Cotton DB, Sorokin Y, Karumanchi SA. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol 2011;204:152.e151-159.
23. Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB, Miranda AS, Teixeira AL, Dusse LM, Sousa LP. Soluble endoglin, transforming growth factor-beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One 2014; 9:e97632.
24. Krauss T, Osmers R, Beran J, Diedrich F, Fleckenstein G, Kuhn W. Soluble adhesion molecules in patients with pre-eclampsia. Zentralbl Gynakol 1998; 120:279-283.
25. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Wolman I, Shenhav M, Lessing JB. Plasma soluble endothelial selectin is elevated in women with pre-eclampsia. Hum Reprod 1998; 13:3537-3541.
26. Ley K, Huo Y. VCAM-1 is critical in atherosclerosis. J Clin Invest 2001; 107:1209-1210.
27. Myatt L, Clifton RG, Roberts JM, Spong CY, Wapner RJ, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Sciscione A, Tolosa JE, Saade G, Sorokin Y, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal- Fetal Medicine Units Network. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population? BJOG 2013; 120:1183-1191.
28. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question. Endocrinology 2004; 145:4835-4837.